Agile Therapeutics (AGRX) News Today $1.95 +0.03 (+1.56%) (As of 12/29/2023 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAgile Therapeutics, Inc. (NASDAQ:AGRX) Short Interest Up 23.9% in Decemberamericanbankingnews.com - December 31 at 3:56 AMAgile Therapeutics (NASDAQ:AGRX) Share Price Passes Above 50 Day Moving Average of $2.03americanbankingnews.com - December 27 at 4:20 AMAgile Therapeutics Provides Update on Actions Being Taken to Strengthen the Affordable Care Act’s No-Cost Contraceptive Coverage Requirementfinance.yahoo.com - December 12 at 9:19 AMAgile Therapeutics reports Q3 resultsmsn.com - November 23 at 8:51 AMAgile Therapeutics Posts Growth In Third Quarter Results, Reiterates Confidence In Target of $25M Net Revenue, Positive Cash Flow In 2024benzinga.com - November 21 at 9:11 AMAgile Therapeutics: A Promising Investment with Positive Cash Flow Forecasts and Anticipated Growth in Twirla Salesmarkets.businessinsider.com - November 11 at 7:49 AMAgile Therapeutics, Inc. (NASDAQ:AGRX) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 10 at 10:58 AMAgile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - November 9 at 8:14 AMAgile Therapeutics Q3 2023 Earnings Previewmsn.com - November 8 at 4:56 PMAgile Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on Thursday, November 9, 2023finance.yahoo.com - October 26 at 8:52 AMAgile Therapeutics, Inc.: Agile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)finanznachrichten.de - October 5 at 9:58 AMAgile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)finance.yahoo.com - October 4 at 6:38 PMAgile Therapeutics, Inc.: Agile Therapeutics Upgraded To "Buy" Rating By Analysts At Maxim Groupfinanznachrichten.de - September 30 at 11:02 PMAgile Therapeutics (NASDAQ: AGRX) Upgraded To “Buy” Rating By Analysts At Maxim Groupfinance.yahoo.com - September 28 at 12:55 PMAgile Therapeutics (NASDAQ: AGRX) Upgraded To "Buy" Rating By Analysts At Maxim Groupbenzinga.com - September 27 at 8:42 AMAgile Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conferencefinance.yahoo.com - September 5 at 5:38 PMAgile ($AGRX) Says It's On Track To Hit $25-$30M Net Annual Revenue After A Strong Performance In Q2msn.com - August 17 at 5:17 PMAgile Therapeutics, Inc. (NASDAQ:AGRX) Q2 2023 Earnings Call Transcriptfinance.yahoo.com - August 11 at 6:10 PMAgile Therapeutics, Inc.: Agile Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Updatefinanznachrichten.de - August 9 at 9:07 PMAgile Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - August 9 at 11:06 AMAgile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023finance.yahoo.com - July 26 at 5:43 PMThis Reproductive Health Company's Weekly Contraceptive Patch Can Reach Millions of Women Thanks to a Partnership With Afaxysfinance.yahoo.com - July 19 at 12:50 PMAgile Therapeutics, Inc.: Agile Therapeutics Partners With Telehealth Platforms To Expand Access To Weekly Birth Control Patch To Millions Of Womenfinanznachrichten.de - July 18 at 10:18 AMNASDAQ: $AGRX Biden's Executive Order Boosts Adoption Of Agile Therapeutics' Contraceptive Patchmsn.com - July 18 at 10:18 AMAgile Therapeutics Partners With Telehealth Platforms To Expand Access To Weekly Birth Control Patch To Millions Of Womenbenzinga.com - July 14 at 9:46 AMAgile Sees Renewed Hope For Even Broader Adoption Of Its Weekly Birth Control Patch After Biden’s Latest Executive Order Expanding Contraceptive Coveragefinance.yahoo.com - July 11 at 1:38 PMAgile Therapeutics (NASDAQ: AGRX)fool.com - July 6 at 1:49 PMAgile Therapeutics Expects Its Innovative Once-A-Week Birth Control Patch To Drive Revenues Of $25-30 Million In 2023 - What Is The Hype All About?finance.yahoo.com - June 30 at 9:40 AMH.C. Wainwright Reiterates Buy Rating For Agile Therapeutics (NASDAQ: AGRX), Citing Growing Demand For Twirla, A Weekly Low Dose Birth Control Patchbenzinga.com - June 29 at 1:30 PMThe Overturning of Roe v. Wade Has Changed the Landscape of Birth Control; Smaller Companies are now an Integral Part of Carefinance.yahoo.com - June 28 at 9:33 AMPresident Biden’s new executive order could help American women get better birth controlfinance.yahoo.com - June 27 at 8:47 PMThis Women's Healthcare Company Raised $7.5 Million In A Public Offering And Says It's Targeting $25 To $30 Million Net Revenue By End Of 2023benzinga.com - June 26 at 10:03 AMAgile Therapeutics Announces the Availability of Twirla® to MMCAP Infuse Membersfinance.yahoo.com - June 26 at 10:03 AMAgile Therapeutics Commends the Biden Administration’s Commitment to Strengthening Access to Affordable, High-Quality Contraception and Family Planning Servicesfinance.yahoo.com - June 23 at 2:40 PMAgile Therapeutics Announces the Availability of Twirla® through FPA Women’s Healthfinance.yahoo.com - June 15 at 6:10 PMAgile Therapeutics Rises on Teaming up with vitaCare for Expanding Twirla’s Reachmsn.com - June 14 at 12:24 PMWhy Agile Therapeutics Stock Is Trading Higher Todayfinance.yahoo.com - June 14 at 12:24 PMAgile Therapeutics Announces New Agreement with vitaCare® Prescription Services to Improve Access to Twirla®finance.yahoo.com - June 13 at 4:22 PMAnalysts Have Conflicting Sentiments on These Healthcare Companies: Agile Therapeutics (AGRX), Check-Cap (CHEK) and Doximity (DOCS)markets.businessinsider.com - June 8 at 6:23 PMAgile Therapeutics, Inc.: Agile Therapeutics Announces Closing of $7.5 Million Public Offeringfinanznachrichten.de - May 26 at 7:52 AMAgile Therapeutics Announces Closing of $7.5 Million Public Offeringfinance.yahoo.com - May 25 at 4:30 PMAgile Therapeutics prices $7.5M offeringmsn.com - May 23 at 7:43 AMAgile Therapeutics Announces Pricing of $7.5 Million Public Offeringfinance.yahoo.com - May 22 at 9:29 PMMaxim Group Sticks to Its Hold Rating for Agile Therapeutics (AGRX)markets.businessinsider.com - May 13 at 8:58 PMQ1 2023 Agile Therapeutics Inc Earnings Callfinance.yahoo.com - May 12 at 9:16 AMAgile Therapeutics: Q1 Earnings Insightsmsn.com - May 11 at 11:11 PMAgile Therapeutics Reports First Quarter 2023 Financial Results And Provides Corporate Updatefinance.yahoo.com - May 11 at 6:11 PMAgile Therapeutics Reports First Quarter 2023 Financial Results And Provides Corporate Updatefinance.yahoo.com - May 11 at 6:11 PMAgile Therapeutics to Report First Quarter 2023 Financial Results and Provide Business Update on Thursday, May 11, 2023finance.yahoo.com - May 8 at 10:03 AMAgile Therapeutics Announces Preliminary Expectations for First Quarter 2023finance.yahoo.com - April 28 at 9:24 AM Get Agile Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AGRX and its competitors with MarketBeat's FREE daily newsletter. Email Address AGRX Media Mentions By Week AGRX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AGRX News Sentiment▼0.510.84▲Average Medical News Sentiment AGRX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AGRX Articles This Week▼41▲AGRX Articles Average Week Get Agile Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AGRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Xenetic Biosciences News Today Monopar Therapeutics News Today Exicure News Today Bright Minds Biosciences News Today Graybug Vision News Today Vallon Pharmaceuticals News Today Hoth Therapeutics News Today Biofrontera News Today 60 Degrees Pharmaceuticals News Today Lipella Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:AGRX) was last updated on 12/31/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agile Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.